Skip to main content
. 2020 Dec 13;12(12):3753. doi: 10.3390/cancers12123753
A2AR A2A-receptor
ADO Extracellular adenosine
CA-IX Carbonic anhydrase IX
CCR CC chemokine receptors
CNS Central nervous system
CTL Cytotoxic T-lymphocyte
CTLA-4 Cytotoxic-T-lymphocyte protein 4
DAPI 4′,6-diamidino-2-phenylindole
GLUT Glucose transporter
H&E Hematoxylin and eosin
HIF Hypoxia-inducible factor
HRP Horseradish peroxidase
ICD Immunogenic cell death
ICI Immune checkpoint inhibitor
IF Immunofluorescence
IHC Immunohistochemistry
IL Interleukin
IPI Ipilimumab
LAG3 Lymphocyte-activation gene 3
LN Lymph node
mAb Monoclonal antibody
MBM Melanoma brain metastases
OS Overall survival
PD-1 Programmed cell death protein 1
ROI Region of interest
RT Radiotherapy
STX Stereotactic brain radiotherapy
TIL Tumor-infiltrating lymphocytes
TME Tumor microenvironment
WBRT Whole-brain radiotherapy